Search Login Register
Cyclooxygenase Inhibitors
Summary
Description:
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.
Also Known As:
Cyclo-Oxygenase Inhibitors; Inhibitors, Cyclo-Oxygenase; Inhibitors, Cyclooxygenase; Inhibitors, Prostaglandin Synthase; Inhibitors, Prostaglandin-Endoperoxide Synthase Show All >>
Networked: 424
relevant articles (32 outcomes,
33 trials/studies)
for this Bio-Agent
Key Diseases for which Cyclooxygenase Inhibitors is
Relevant
-
Inflammation
:
5 outcomes 4 studies in 46 results
-
Pain (Aches)
:
3 outcomes 2 studies in 24 results
-
Asthma (Bronchial Asthma)
:
2 outcomes 1 study in 11 results
-
Rheumatic Diseases (Rheumatism)
:
2 outcomes in 3 results
-
Neoplasms (Cancer)
:
1 outcome 6 studies in 37 results
Show All >>
Drugs Related to Cyclooxygenase Inhibitors
-
Indomethacin (Indometacin)
-
Aspirin (Acetylsalicylic Acid)
-
Lipoxygenase (Lipoxygenase-1)
-
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
-
Opioid Analgesics (Opioids)
-
N-Methylaspartate (NMDA)
-
Ibuprofen (Motrin)
-
Dinoprostone (PGE2)
-
Prostaglandins
-
Lipoxygenase Inhibitors
Show All >>
Therapies Related to Cyclooxygenase Inhibitors
-
Chemoprevention
-
Drug Therapy (Chemotherapy)
-
Immunotherapy
-
Transplants (Transplant)
-
Heterologous Transplantation (Xenotransplantation)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.